{
    "clinical_study": {
        "@rank": "112520", 
        "arm_group": {
            "arm_group_label": "ISB and IC-Green Dye", 
            "description": "The dose of ISB dye is 3 to 5 mL and IC-Green\u2122 will be started at 1 mg/mL.  If fluorescence is not detected with this dose, then it will be increased by 50%. A gamma probe [Neoprobe 2010] will be used to localize the sentinel lymph nodes in the axilla."
        }, 
        "brief_summary": {
            "textblock": "To determine concordance between isosulfan blue (ISB) and indocyanine green (IC-GREEN\u2122) in\n      the identification of lymphatics and arm-draining nodes during nodal staging procedures in\n      breast cancer."
        }, 
        "brief_title": "Pilot Indocyanine Green\u2122 Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer", 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ability to understand and the willingness to sign a written informed consent\n             document.\n\n          -  Signed written informed consent.\n\n          -  Women undergoing sentinel lymph node biopsy.\n\n          -  Women with breast cancer with known or suspected lymph node involvement.\n\n          -  Women undergoing sentinel node identification and completion axillary lymph node\n             dissection.\n\n          -  Women of 18 years of age or older.\n\n          -  Eastern Cooperative Oncology Group (ECOG) or Karnofsky Performance Status 0,1,2.\n\n          -  Complete Blood Count (CBC) and basic Metabolic Panel within 6 months\n\n        Exclusion Criteria:\n\n          -  History of liver or kidney failure will not be eligible.\n\n          -  Allergies to iodine containing products will not be eligible.\n\n          -  Women who are pregnant will not be eligible.\n\n          -  Psychiatric or addictive disorders or other conditions that, in the opinion of the\n             investigator, would preclude the patient from meeting the study requirements."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Women undergoing sentinel node resection with or without axillary lymph node dissection\n        (ALND) for breast cancer"
            }
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01771666", 
            "org_study_id": "BRS0022", 
            "secondary_id": [
                "SU-06122012-10130", 
                "21030"
            ]
        }, 
        "intervention": {
            "arm_group_label": "ISB and IC-Green Dye", 
            "intervention_name": "(IC-GREEN\u2122) SPY Elite\u00ae Imaging", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 25, 2013", 
        "location": {
            "contact": {
                "email": "smeyer27@stanford.edu", 
                "last_name": "Shannon Meyer", 
                "phone": "650-724-1953"
            }, 
            "facility": {
                "address": {
                    "city": "Stanford", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94305"
                }, 
                "name": "Stanford University Cancer Institute"
            }, 
            "investigator": {
                "last_name": "Irene Wapnir", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Pilot Study to Assess the Utility of Indocyanine Green\u2122 (IC-GREEN\u2122) SPY Imaging in the Mapping of Arm Draining Lymphatics and Nodes During Sentinel Node Resection With or Without Axillary Dissection in Breast Cancer", 
        "overall_contact": {
            "email": "smeyer27@stanford.edu", 
            "last_name": "Shannon Meyer", 
            "phone": "6507241953"
        }, 
        "overall_official": {
            "affiliation": "Stanford University", 
            "last_name": "Irene Wapnir", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Percent of patients with blue and fluorescent lymphatics and nodes", 
            "safety_issue": "No", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01771666"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Percentage of blue sentinel nodes or with ex-vivo fluorescence", 
            "safety_issue": "No", 
            "time_frame": "1 month"
        }, 
        "source": "Stanford University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Stanford University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}